PLDT Automation Rollout Could Be A Big Test For UiPath (PATH)

• UiPath reported that PLDT in the Philippines expanded its use of the UiPath Platform, rolling out AI based tools like KAI, Ellie, and ERICA to cut manual work and accelerate customer and risk processes across growing 5G, broadband, and satellite demand.
• The PLDT deployment shows UiPath software being embedded into core workflows at scale, turning large volumes of fragmented internal data into faster decisions and freeing staff capacity, rather than just automating isolated back office tasks.
• We will now look at how UiPath's investment narrative intersects with PLDT's scaled automation rollout using its AI driven platform.

Scan beyond UiPath and size up other automation and robotics plays by reviewing the curated 95 robotics and automation stocks that could benefit as AI driven workflows become standard.

UiPath Investment Narrative Recap

To own UiPath, you need to believe in broad adoption of its automation and agentic AI platform across existing and new customers, with deeper usage per account rather than only adding logos. The PLDT rollout supports this platform usage story but, on its own, does not materially shift the near term picture.

In the short term, the key swing factor is how quickly enterprises commit to larger, multi product deployments while macro and budget caution persist. The biggest risk still sits around delayed deal closures and the SaaS transition acting as a drag on reported growth, especially if newer agentic products take longer to show up meaningfully in revenue.

The most relevant update alongside the PLDT news is UiPath's share repurchase activity, with 8,737,000 shares bought back for US$86.67m under the program announced in March 2026. That is a modest reduction in the share count relative to the US$7.17b market value and does not change the business trajectory.

For you as an investor, the buyback mainly affects how future earnings per share flow to remaining holders, if the company sustains profitability. Execution still hinges on turning customer case studies like PLDT into broader platform adoption, while managing FX headwinds, SaaS related growth friction, and timing of large automation budgets.

UiPath's narrative projects US$2.2b revenue and US$346.4m earnings by 2029. This implies 8.1% yearly revenue growth and an earnings decline of US$15.5m from current earnings of US$361.9m.

Uncover how UiPath's fair value indicates a 26% potential upside to its current price before the market closes that gap.

Exploring Other Perspectives

One alternate view on UiPath focuses on valuation risk rather than deal timing. The most bearish analysts were assuming about US$2.0b in 2029 revenue and US$514.9m in earnings, paired with a much lower 13.4x P/E. That is a far more cautious story than consensus, and the PLDT and India marketing news could eventually reshape it.

Explore 6 other UiPath fair value estimates, including one that suggests it could be worth just $16.85!

Decide For Yourself

Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

• A great starting point for your UiPath research is our analysis highlighting 4 key rewards that could impact your investment decision.
• See our latest analysis for UiPath. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate UiPath's overall financial health at a glance.

Looking For More Investment Ideas Beyond UiPath?

If the UiPath story has you thinking about where automation, cash flows, and balance sheet strength intersect, broaden the search using the Simply Wall St Screener and line up a few alternatives next to it.

• For investors hunting for value with quality baked in, review 33 high quality undervalued stocks which already stack up well on both cash generation and financial strength.
• If income matters more to you than headlines, consider screening through 6 dividend fortresses which pair higher yields with a focus on resilience.
• When capital preservation sits at the top of your checklist, narrow your watchlist to 30 resilient stocks with low risk scores which score well on stability metrics and risk controls.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com